1995
DOI: 10.1200/jco.1995.13.10.2503
|View full text |Cite
|
Sign up to set email alerts
|

Pubertal growth in young adult survivors of childhood leukemia.

Abstract: Purpose:To determine the effect of cranial irradiation (18 Gy and 24 Gy) on pubertal growth in young adult survivors of childhood acute lymphoblastic leukemia (ALL).Patients and Methods: Final height (FH) and pubertal growth were retrospectively examined in 142 young adult survivors of childhood ALL. All were in first remission and had received either 18 or 24 Gy of cranial irradiation. Eighty-four children (48 girls) were treated with 24 Gy and 58 (35 girls) with 18 Gy. None had received either testicular or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
1

Year Published

1998
1998
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 60 publications
(20 citation statements)
references
References 17 publications
1
18
1
Order By: Relevance
“…The age of peak height velocity (PHV) is often thought of as the gold standard of non-invasive measures of maturational status in observational studies. Age at PHV has been widely used as an outcome (Didcock et al, 1995;Mason et al, 2011;Nielsen, 1985;Price et al, 1988), exposure of interest (Gastin et al, 2013;Mao et al, 2013;Sherar et al, 2007), or as a covariate to control for confounding (Baxter-Jones et al, 2011;Darelid et al, 2012;Forwood et al, 2004). The appeal of age at PHV is twofold: (1) it applies equally to both boys and girls (Sherar et al, 2004); and (2) the measure appears to be objective, particularly in comparison to other methods that rely on subjective decisions about physical development of primary (Taranger et al, 1976) (orchoidometry) and secondary sex characteristics (Tanner, 1962) (Tanner Staging), recall of (semi-) specific biological events (age at menarche (Bergsten-Brucefors, 1976;Damon & Bajema, 1974;Damon et al, 1969)/voice breaking (Billewicz et al, 1981;Hagg & Taranger, 1980)), comparison of skeletal (Greulich & Pyle, 1959;Roche, 1988;Tanner et al, 1962Tanner et al, , 1975 and dental (Demirjian & Goldstein, 1976) radiographs with pre-defined standards or description or as a percentage of predicted adult stature (Bayley & Pinneau, 1952;Khamis & Roche, 1994;Roche et al, 1975;Tanner et al, 1975).…”
Section: Introductionmentioning
confidence: 99%
“…The age of peak height velocity (PHV) is often thought of as the gold standard of non-invasive measures of maturational status in observational studies. Age at PHV has been widely used as an outcome (Didcock et al, 1995;Mason et al, 2011;Nielsen, 1985;Price et al, 1988), exposure of interest (Gastin et al, 2013;Mao et al, 2013;Sherar et al, 2007), or as a covariate to control for confounding (Baxter-Jones et al, 2011;Darelid et al, 2012;Forwood et al, 2004). The appeal of age at PHV is twofold: (1) it applies equally to both boys and girls (Sherar et al, 2004); and (2) the measure appears to be objective, particularly in comparison to other methods that rely on subjective decisions about physical development of primary (Taranger et al, 1976) (orchoidometry) and secondary sex characteristics (Tanner, 1962) (Tanner Staging), recall of (semi-) specific biological events (age at menarche (Bergsten-Brucefors, 1976;Damon & Bajema, 1974;Damon et al, 1969)/voice breaking (Billewicz et al, 1981;Hagg & Taranger, 1980)), comparison of skeletal (Greulich & Pyle, 1959;Roche, 1988;Tanner et al, 1962Tanner et al, , 1975 and dental (Demirjian & Goldstein, 1976) radiographs with pre-defined standards or description or as a percentage of predicted adult stature (Bayley & Pinneau, 1952;Khamis & Roche, 1994;Roche et al, 1975;Tanner et al, 1975).…”
Section: Introductionmentioning
confidence: 99%
“…A number of survivors suffer long-term side effects from their treatment, including intellectual impairment, disorders of growth, cardiac damage, and second malignancies. [4][5][6][7][8] A reduction in both the mortality rate and the toxic consequences of treatment remains a challenge for the improvement of ALL therapy in the future.…”
Section: Introductionmentioning
confidence: 99%
“…In ALL girls, the timing of puberty is only moderately altered, with mean PHV at 10.7–11.0 years vs. 12.1 years in normals and mean timing of menarche at 12.2–12.3 years vs. 13.4 years, respectively [6]. Furthermore, the degree of GHD in ALL children is usually more subtle than in brain tumour children.…”
Section: Acute Lymphoblastic Leukaemiamentioning
confidence: 99%
“…Paradoxically, lower doses of irradiation may be associated with early puberty. In children irradiated with a dose of 2,500–4,750 cGy for a brain tumour, both genders are affected [3]; however, after a dose of 1,800–2,400 cGy for acute lymphoblastic leukaemia (ALL) only girls enter puberty early [4, 5, 6]. Thus, the capacity of radiation-induced damage to the central nervous system to induce early puberty is dose- related and the dose threshold for this effect is gender-specific.…”
Section: Cranial Irradiation and Pubertymentioning
confidence: 99%
See 1 more Smart Citation